Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

E. C. van Dalen; H. J. H. van der Pal; L. C. M. Kremer

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

E. C. van Dalen, H. J. H. van der Pal, L. C. M. Kremer

Research output: Contribution to journal › Review article › Academic › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: (1) To determine the cardiotoxicity of any type of dosage schedule for anthracycline chemotherapy in patients with cancer when compared to another type of dosage schedule. Secondary objectives: (1) To determine possible effects of these dosage schedules on tumour response and patient survival. (2) To determine possible effects of these dosage schedules on toxicities other than cardiac damage and quality of life

Original language	English
Pages (from-to)	CD005008
Journal	Cochrane database of systematic reviews (Online)
Volume	2004
Issue number	3
Publication status	Published - 2004

Cite this

@article{74ba9ed6868943f9b2fcfb040391e93b,

title = "Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: (1) To determine the cardiotoxicity of any type of dosage schedule for anthracycline chemotherapy in patients with cancer when compared to another type of dosage schedule. Secondary objectives: (1) To determine possible effects of these dosage schedules on tumour response and patient survival. (2) To determine possible effects of these dosage schedules on toxicities other than cardiac damage and quality of life",

author = "{van Dalen}, {E. C.} and {van der Pal}, {H. J. H.} and Kremer, {L. C. M.}",

year = "2004",

language = "English",

volume = "2004",

pages = "CD005008",

journal = "Cochrane database of systematic reviews (Online)",

issn = "1464-780X",

publisher = "Wiley",

number = "3",

}

TY - JOUR

T1 - Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

AU - van Dalen, E. C.

AU - van der Pal, H. J. H.

AU - Kremer, L. C. M.

PY - 2004

Y1 - 2004

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: (1) To determine the cardiotoxicity of any type of dosage schedule for anthracycline chemotherapy in patients with cancer when compared to another type of dosage schedule. Secondary objectives: (1) To determine possible effects of these dosage schedules on tumour response and patient survival. (2) To determine possible effects of these dosage schedules on toxicities other than cardiac damage and quality of life

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Primary objective: (1) To determine the cardiotoxicity of any type of dosage schedule for anthracycline chemotherapy in patients with cancer when compared to another type of dosage schedule. Secondary objectives: (1) To determine possible effects of these dosage schedules on tumour response and patient survival. (2) To determine possible effects of these dosage schedules on toxicities other than cardiac damage and quality of life

M3 - Review article

SN - 1464-780X

VL - 2004

SP - CD005008

JO - Cochrane database of systematic reviews (Online)

JF - Cochrane database of systematic reviews (Online)

IS - 3

ER -